Events
For the past 29 years, PharmaVentures has acted as advisor on over 900 deal related projects covering licensing, mergers, acquisitions, divestments, and joint venture activities for companies world-wide
We have unrivalled strategic insight in the commercialisation and transaction of assets and companies in the pharmaceutical, biotech, medtech and diagnostics sectors. We have been trusted by major corporations, high growth biotechs and emerging companies to provide insight and advice to help these businesses achieve their strategic goals. Operating globally in M&A, licensing, divestments and fundraising, we have the skills and experience to help you drive your business forward.
PharmaVentures attends key conferences and meetings to discuss our services and we also attend events on behalf of our clients, promoting advisory mandates in M&A and licensing across the life science sector.
How To Meet Us
We often have opportunities that could be transformative to your business, especially with the optimal strategy and best execution.
Our team attending these events are available to speak with you about your own requirements. To book a meeting, email us at:
Upcoming events
5-8 October 2021
Sachs HealthTech Investment and Biotech Forum
Dr Fintan Walton, Founder & CEO, will be charing a session and Mark Andrews, Managing Director, will be participating in a panel discussion.
11-13 October 2021
CPhI Korea
Dr Luke Lee, Associate, will be available for 1-1 meetings.
Find out more about PharmaVentures’ Korean Market Expertise
25-28 October 2021
BIO-Europe
Vanessa Carle, Associate, will be available for 1-1 meetings.
9-11 November 2021
CPhI Worldwide
Mark Andrews, Managing Director and Dr Jansen Jacob, Vice President, will be available for 1-1 meetings.
15-18 November 2021
MEDICA Trade Fair
Dr Adrian Dawkes, Managing Director, and Mark Andrews, Managing Director will be available for 1-1 meetings.
Recent events
23 September 2021
BioForward
Vanessa Carle, Associate, attended this event in person.
20-23 September 2021
BIOPHARM AMERICA
Vanessa Carle, Associate, attended 1-1 networking meetings.
15 September 2021
N-Site Expert Advice Clinic
Dr Adrian Dawkes, Managing Director attended this virtual event and took part in 1-1 meetings.
10-12 August 2021
CPhI North America
Mark Andrews and Dr Jansen Jacob, attended 1-1 networking meetings.
5-6 July 2021
ON Helix Digital
Vanessa Carle, Associate, attended 1-1 networking meetings.
21-25 June 2021
BioTrinity 2021
Dr Adrian Dawkes, Managing Director, attended 1-1 partnering meetings.
16-18 June 2021
BIO Digital 2021
Dr Adrian Dawkes and Stephen Walterman attended 1-1 partnering meetings.
9-21 June 2021
BIO KOREA 2021
Dr Fintan Walton & Dr Adrian Dawkes presented at BIO Korea. Find out more about PharmaVentures’ Korean Market Expertise.
19 May 2021
BIA Start-up Festival
Mark Andrews, Managing Director chaired a panel discussion and Dr Adrian Dawkes attended 1-1 meetings.
17-19 May 2021
BIO-Equity Europe
Mark Andrews, Managing Director attended this virtual event.
28-30 April 2021
Sachs Neuroscience Innovation Forum
Mark Andrews, Managing Director attended this virtual event.
10-15 April 2021
AACR Annual Meeting
Dr Adrian Dawkes, Managing Director, attended this virtual event.
22-25 March 2021
BIO-Europe Spring Digital 2021
Summer Park, Senior Business Development Director attended this virtual event.
11 March 2021
N-Site Expert Advice Clinic
Dr Adrian Dawkes, Managing Director attended this virtual event and took part in 1-1 meetings.
PharmaVentures InSights:
The impact of conference cancellations on dealmaking
during the Covid-19 pandemic
Can Partnering Conference Cancellations Affect Dealmaking in 2020?
We all got used to the partnering conference circuit as a means to introduce the latest developments to potential partners. So now they are all temporarily suspended whilst we overcome the current global health challenge, how do you make sure your opportunities are still getting in front of your potential partners.
PharmaVentures has been successfully connecting buyers and sellers for over 28 years with and without partnering conferences.
PharmaVentures’ CEO, Dr. Fintan Walton talks about how PharmaVentures is continuing a business as usual approach for all of our clients.
Don’t hesitate to contact us to help you carry on dealmaking.